Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin Zounemat Kermani

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Immunology|March 5, 2024
Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti-breast cancer immunity: An in vitro studyAmirhossein Jahangiri, Rana Ezzeddini, Nazanin Zounemat Kermani, et al.
Advances in Experimental Medicine and Biology|July 18, 2023
Systems Biology in AsthmaNazanin Zounemat Kermani, Ian M Adcock, Ratko Djukanović, et al.
Briefings in Bioinformatics|January 11, 2024
Consensus clustering with missing labels (ccml): a consensus clustering tool for multi-omics integrative prediction in cohorts with unequal sample coverageChuan-Xing Li, Hongyan Chen, Nazanin Zounemat-Kermani, et al.
Allergy|August 3, 2020
Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotypeAngelica Tiotiu, Nazanin Zounemat Kermani, Yusef Badi, et al.
Allergy|January 3, 2025
The Role of WNT5a and TGF-β1 in Airway Remodelling and Severe AsthmaTariq Daud, Sheree Roberts, Nazanin Zounemat Kermani, et al.
Allergy|April 7, 2023
Epithelium-derived cystatin SN inhibits house dust mite protease activity in allergic asthmaLei Yao, Xijing Yuan, Heng Fu, et al.
Ebiomedicine|December 21, 2023
Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputumKhezia Asamoah, Kian Fan Chung, Nazanin Zounemat Kermani, et al.
Cardio-Oncology (London, England)|July 15, 2024
Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk scoreFiona Fernando, Maria Sol Andres, Simone Claudiani, et al.
Allergy|July 9, 2026
Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe AsthmaFreda Yang, Sujin Seo, Takehiro Hasegawa, et al.
Allergy|December 8, 2025
Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U-BIOPRED CohortJoana Antão, Guilherme Rodrigues, Nazanin Zounemat-Kermani, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Immunology|March 5, 2024
Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti-breast cancer immunity: An in vitro studyAmirhossein Jahangiri, Rana Ezzeddini, Nazanin Zounemat Kermani, et al.
Advances in Experimental Medicine and Biology|July 18, 2023
Systems Biology in AsthmaNazanin Zounemat Kermani, Ian M Adcock, Ratko Djukanović, et al.
Briefings in Bioinformatics|January 11, 2024
Consensus clustering with missing labels (ccml): a consensus clustering tool for multi-omics integrative prediction in cohorts with unequal sample coverageChuan-Xing Li, Hongyan Chen, Nazanin Zounemat-Kermani, et al.
Allergy|August 3, 2020
Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotypeAngelica Tiotiu, Nazanin Zounemat Kermani, Yusef Badi, et al.
Allergy|January 3, 2025
The Role of WNT5a and TGF-β1 in Airway Remodelling and Severe AsthmaTariq Daud, Sheree Roberts, Nazanin Zounemat Kermani, et al.
Allergy|April 7, 2023
Epithelium-derived cystatin SN inhibits house dust mite protease activity in allergic asthmaLei Yao, Xijing Yuan, Heng Fu, et al.
Ebiomedicine|December 21, 2023
Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputumKhezia Asamoah, Kian Fan Chung, Nazanin Zounemat Kermani, et al.
Cardio-Oncology (London, England)|July 15, 2024
Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk scoreFiona Fernando, Maria Sol Andres, Simone Claudiani, et al.
Allergy|July 9, 2026
Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe AsthmaFreda Yang, Sujin Seo, Takehiro Hasegawa, et al.
Allergy|December 8, 2025
Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U-BIOPRED CohortJoana Antão, Guilherme Rodrigues, Nazanin Zounemat-Kermani, et al.
Pageof 4